Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Adamas Pharmaceuticals Inc (ADMS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2022 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in Adamas Pharmaceuticals, Inc. |
02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/26/2022 |
SC 13G/A
| Opaleye Management Inc. reports a 0% stake in Adamas Pharmaceuticals, Inc. |
12/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
10/20/2021 |
SC 13G/A
| HIRSCHMAN ORIN reports a 12% stake in Adamas Pharmaceuticals, Inc. |
02/16/2021 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 9.6% stake in Adamas Pharmaceuticals, Inc. |
02/12/2021 |
SC 13G/A
| Opaleye Management Inc. reports a 5.2% stake in ADAMAS PHARMACEUTICALS, INC. |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
07/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| Went Gregory T reports a 5% stake in Adamas Pharmaceuticals, Inc. |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/07/2020 |
SC 13G/A
| INTEGRATED CORE STRATEGIES LLC reports a 0% stake in ADAMAS PHARMACEUTICALS, INC. |
02/05/2020 |
SC 13G/A
| Invesco Ltd. reports a 0% stake in Adamas Pharmaceuticals Inc |
02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 6.2% stake in ADAMAS PHARMACEUTICALS INC |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2019 |
SC 13G/A
| Went Gregory T reports a 5.2% stake in Adamas Pharmaceuticals, Inc. |
02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/02/2019 |
SC 13G/A
| Brenner West Capital Advisors, LLC reports a 0% stake in Adamas Pharmaceuticals, Inc. |
10/10/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
04/10/2018 |
SC 13G/A
| STATE STREET CORP reports a 10.5% stake in AMENDED FILING ADAMAS PHARMACEUTICALS, INC. |
03/08/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2018 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 8.2% stake in ADAMAS PHARMACEUTICALS, INC. |
02/14/2018 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in Adamas Pharmaceuticals, Inc. |
02/14/2018 |
SC 13G/A
| BOW STREET, LLC reports a 0% stake in Adamas Pharmaceuticals, Inc. |
02/14/2018 |
SC 13G/A
| Brenner West Capital Advisors, LLC reports a 5.6% stake in Adamas Pharmaceuticals, Inc. |
02/13/2018 |
SC 13G/A
| Kerrisdale Advisers, LLC reports a 0.4% stake in ADAMAS PHARMACEUTICALS, INC. |
02/13/2018 |
SC 13G/A
| STATE STREET CORP reports a 6% stake in ADAMAS PHARMACEUTICALS, INC. |
|
|
|